The lipid raft protein NTAL participates in AKT signaling in mantle cell lymphoma

• Published in: Leukemia & lymphoma Vol. 60; no. 11; pp. 2658 - 2668
• Main Authors: Ferreira, Germano Aguiar, Thomé, Carolina Hassibe, Simão, Ana Maria Sper, Scheucher, Priscila Santos, Silva, Cleide Lúcia Araújo, Chahud, Fernando, Ciancaglini, Pietro, Leopoldino, Andreia Machado, Rego, Eduardo Magalhães, Faça, Vitor Marcel, dos Santos, Guilherme Augusto
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 19.09.2019
• Subjects: Adaptor proteins; AKT; lipid rafts; lymphoma; Adaptor proteins; lipid rafts; AKT; lymphoma
• ISSN: 1042-8194; 1029-2403
• DOI: 10.1080/10428194.2019.1607326

Lipid rafts are ordered membrane domains, which provide an environment for the proteins participating in signal transduction. Perifosine is an alkylphospholipid (APL) that inhibits the AKT pathway, cytotoxic to neoplastic cells. We have shown that the lipid raft adaptor protein NTAL is a target of APLs in leukemic cells. Using human mantle cell lymphoma (MCL) Granta-519 cell line we showed here that perifosine decreased NTAL in lipid raft fractions reducing AKT phosphorylation before apoptosis. We also showed that the NTAL-knockdown by shRNA induced a state of reduced AKT activation. Experimental NTAL-knockdown in NSG mouse MCL xenografts reduced AKT activity, increased the basal apoptotic rate by 3-fold (n = 8) and decreased tumor weight by 2.7-fold (n = 5), indicating that NTAL participates in tumor growth. NTAL protein was detected by western blotting in circulating cells of 7 of 8 MCL patients in the leukemic phase, suggesting involvement in the progression of the disease.